Gene · 8398
Papers2,402
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
201 to 220 of 2,402
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The Involvement of Polyunsaturated Fatty Acids in Apoptosis Mechanisms and Their Implications in Cancer. | Int J Mol Sci | 2023 | 37511450 | PubTator, text mining | PubMed |
| Mitochondrial Neurodegenerative Diseases: Three Mitochondrial Ribosomal Proteins as Intermediate Stage in the Pathway That Associates Damaged Genes with Alzheimer's and Parkinson's. | Biology (Basel) | 2023 | 37508402 | PubTator, text mining | PubMed |
| Cross-Species Transcriptomics Analysis Highlights Conserved Molecular Responses to Per- and Polyfluoroalkyl Substances. | Toxics | 2023 | 37505532 | PubTator, text mining | PubMed |
| Alternative Targets for sPLA2 Activity: Role of Membrane-Enzyme Interactions. | Membranes (Basel) | 2023 | 37504984 | PubTator, text mining | PubMed |
| Diagnosis, treatment and genetic analysis of a child with infantile neuroaxonal dystrophy. | Yi Chuan | 2023 | 37503585 | PubTator, text mining | PubMed |
| Uncovering ferroptosis in Parkinson's disease via bioinformatics and machine learning, and reversed deducing potential therapeutic natural products. | Front Genet | 2023 | 37485340 | PubTator, text mining | PubMed |
| Development of CRISPR Cas9, spin-off technologies and their application in model construction and potential therapeutic methods of Parkinson's disease. | Front Neurosci | 2023 | 37483347 | PubTator, text mining | PubMed |
| RINT1 deficiency disrupts lipid metabolism and underlies a complex hereditary spastic paraplegia. | J Clin Invest | 2023 | 37463447 | PubTator, text mining | PubMed |
| Correction: Phenotype and genotype heterogeneity of PLA2G6-associated neurodegeneration in a cohort of pediatric and adult patients. | Orphanet J Rare Dis | 2023 | 37461050 | PubTator, text mining | PubMed |
| Specialized Pro-Resolving Lipid Mediators: Endogenous Roles and Pharmacological Activities in Infections. | Molecules | 2023 | 37446699 | PubTator, text mining | PubMed |
| Ferritin light chain promotes the reprogramming of glioma immune microenvironment and facilitates glioma progression. | Theranostics | 2023 | 37441589 | PubTator, text mining | PubMed |
| Calcium dysregulation combined with mitochondrial failure and electrophysiological maturity converge in Parkinson's iPSC-dopamine neurons. | iScience | 2023 | 37426342 | PubTator, text mining | PubMed |
| Identification of four secretory phospholipase A2s in a lepidopteran insect, Acrolepiopsis sapporensis, and their functional association with cellular immune responses. | Front Endocrinol (Lausanne) | 2023 | 37424852 | PubTator, text mining | PubMed |
| Phenotype and genotype heterogeneity of PLA2G6-associated neurodegeneration in a cohort of pediatric and adult patients. | Orphanet J Rare Dis | 2023 | 37403138 | PubTator, text mining | PubMed |
| Ferrostatin-1 attenuates brain injury in animal model of subarachnoid hemorrhage via phospholipase A2 activity of PRDX6. | Neuroreport | 2023 | 37395228 | PubTator, text mining | PubMed |
| Treatment mechanism of immune triad from the repurposing drug against COVID-19. | Transl Med Aging | 2023 | 37388715 | PubTator, text mining | PubMed |
| Ferroptosis and the bidirectional regulatory factor p53. | Cell Death Discov | 2023 | 37386007 | PubTator, text mining | PubMed |
| Application of codon usage and context analysis in genes up- or down-regulated in neurodegeneration and cancer to combat comorbidities. | Front Mol Neurosci | 2023 | 37383425 | PubTator, text mining | PubMed |
| Neurobiology of Parkinson's Disease. | Int J Mol Sci | 2023 | 37373081 | PubTator, text mining | PubMed |
| Brain Iron Metabolism, Redox Balance and Neurological Diseases. | Antioxidants (Basel) | 2023 | 37372019 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8398/papers?page=11